Synta Pharmaceuticals Announces Appointment of Sumant Ramachandra, M.D., Ph.D. as President, Research and Development

Published: Mar 14, 2013

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the appointment of Dr. Sumant Ramachandra as President, Research and Development.

Prior to Synta, Dr. Ramachandra was Senior Vice President, Research and Development (R&D), Regulatory and Medical Affairs, and Chief Scientific Officer of Hospira, a specialty pharmaceuticals and medical device company.

Back to news